The growth of the heparin market is driven by an increase in the number of patients undergoing coronary heart disease and myocardial infarction, venous thromboembolism and cardiovascular disorders, and an aging population. Heparin is a glycosaminoglycan that occurs naturally. It is used in medicine as an anticoagulant (blood thinner). It is particularly useful in the treatment of heart attacks and unstable angina. It is injected into a vein or injected under the skin.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/6551
A major factor driving the growth of the heparin market is the increase in the incidence of venous thrombosis as a result of various underlying factors such as cardiovascular diseases. Moreover, the use of heparin in various operations such as orthopedic and cardiac surgeries as well as the increase in the number of patients undergoing such procedures is driving the market growth. However, several negative side effects associated with heparin, such as heparin-induced thrombocytopenia, limit the market growth. Moreover, since heparin is derived from animal sources, it raises key safety and supply concerns, which also hampers market growth.
Purchase Inquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/6551
Increased government support to improve healthcare infrastructure and strong R&D initiatives to produce heparin with improved therapeutic potential and fewer side effects are expected to create lucrative opportunities for the industry.
Europe accounted for the largest share of the global heparin market in 2020 and is expected to remain dominant during the forecast period. This was attributed to the increase in sports injuries and cardiovascular disorders and the increasing demand for heparin for cardiovascular diseases and sports injuries. High level of healthcare expenditure, high patient awareness and sophisticated healthcare infrastructure can contribute to the region’s high share. In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to the increasing aging population and increasing prevalence of long-term survivors of acute myocardial infarction (AMI).
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ:
- Based on product, the low molecular weight heparin segment held the largest heparin market share in the global market in 2020.
- On the basis of application, the venous thromboembolism segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
- On the basis of distribution channel, the hospital pharmacies segment held the largest heparin market share in 2020 and is expected to remain dominant during the forecast period.
- Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.8% during the forecast period.
Customization Request@ https://www.alliedmarketresearch.com/request-for-customization/6551
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
The key market players profiled in the report include Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddyโs Laboratories Ltd., Fresenius SE & Co KGaA, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Leo Pharma A/S, Pfizer Inc., Sanofi S.A, Teva Pharmaceuticals, and Viatris Inc.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Biosensors Market: https://www.alliedmarketresearch.com/biosensors-market
Deep Brain Stimulation Devices Market: https://www.alliedmarketresearch.com/deep-brain-stimulation-devices-market
X-Ray Detector Market: https://www.alliedmarketresearch.com/x-ray-detectors-market
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com